共 17 条
[1]
Prostaglandin E1: a new agent for the prevention of renal dysfunction in high risk patients caused by radiocontrast media. Jens K,J?rg P,Bernd G.etal. Nephrology Dialysis Transplantation . 2000
[2]
Prevention of radiocontrast-induced nephropathy. Asif A,Epstein M. American Journal of Kidney Diseases . 2004
[3]
Calcium-channel blockers for prophylaxis of radiocontrast-associated nephrotoxicity. Seyss C,Foote F. Annals of Pharmacotherapy . 1995
[4]
Exacerbation of radiocontrast nephrotoxicity by endothelin receptor antagonism. Wang A,Holcslaw T,Bashore M,et al. Kidney International . 2000
[5]
Prevention of contrast media associated nephropathy. Christian M,Gerd B,Heinz B. Archives of Internal Medicine . 2002
[6]
Nephrotoxicity and the role of contrast media. Peter A. Radiation Medicine . 2004
[7]
Theophylline for the prevention of radiocontrast nephropathy: a meta-analysis. Ix JH,McCulloch CE,Chertow GM. Dialysis and Transplantation . 2004
[8]
Current trials of interventions to prevent radiocontrast-induced nephropathy. Arif A,Galo G,Rechard A,et al. American Journal of Therapeutics . 2005
[9]
Prevention of radiocontrast-induced nephropathy by adenosine antagonists in rats with chronic nitric oxide deficiency. Erley M,Heyne N,Burgert K,et al. Journal of the American Society of Nephrology . 1997
[10]
Radiocontrast-induced renal tubular cell apoptosis: hypertonic versus oxida-tive stress. Hizou I,Haller C. Investigative Radiology . 2002